Biota, Inc. Obtains US$2.9M National Institutes of Health (NIH) Grant for the Development of Novel Antibacterial

Published: Jun 10, 2011

MELBOURNE, Australia--(BUSINESS WIRE)--Biota Holdings Limited (ASX:BTA) advises that its wholly owned subsidiary, Biota Scientific Management Pty Ltd, has been awarded a grant to fund the preclinical development of a lead candidate for the treatment of Clostridium difficile (C. difficile).

Back to news